Kidney
CA266-0008
A phase 1/2 study of BMS-986545/BNT-327 in combination with ipilimumab or cabozantinib in participants with previously untreated advanced RCC.
Trial overview
Clinical Area
Medical Oncology
Disease
Kidney
Disease site
Genitourinary (GU)
Study Phase
I
Trial Identifiers
Registration number: NCT07293351
GenesisCare Location(s)
Principal Investigator(s)